Latest news
Merck (NYSE:MRK): Can new products offset the coming patent cliff? - Kalkine MediaKalkine Media · Fri, 07 Aug 2026 16:59:00 GMTCan Merck (NYSE:MRK) Offset The Coming Keytruda Patent Cliff? - Kalkine MediaKalkine Media · Thu, 06 Aug 2026 19:29:00 GMTHow Stronger 2026 Guidance And New Drug Indications At Merck (MRK) Has Changed Its Investment Story - simplywall.stsimplywall.st · Thu, 06 Aug 2026 13:35:36 GMTMRK Q2 Earnings Call Puts Pipeline Progress in Focus - The Globe and MailThe Globe and Mail · Wed, 05 Aug 2026 15:14:00 GMTMerck is pharma’s most patent-exposed company. Now it’s reinventing itself. - Pharma VoicePharma Voice · Wed, 05 Aug 2026 13:30:22 GMTMerck advances sac-TMT into first-line lung cancer redesign after endometrial Phase III win - AllSciAllSci · Wed, 05 Aug 2026 09:44:57 GMTMerck CEO Rob Davis: We have a franchise that will stand the test of time - CNBCCNBC · Tue, 04 Aug 2026 23:52:00 GMTAs FDA makes Lipfendra poster child of CNPV pilot, Merck charts long-term path for first PCSK9 pill - Fierce PharmaFierce Pharma · Tue, 04 Aug 2026 18:38:51 GMT